| Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961) |
|---|
| 01/10/2008 | US20080009617 Amidating 2-nitrophenylacetic acid with 4-amino-N-phenylmethylpiperidine; hydrogenating the nitro group; carbamylating the amine formed with a dicarbonate or chloroformate; dissolving product in an aprotic organic solvent; reduction and cyclization; cleaving the benzyl protecting group |
| 01/10/2008 | US20080009481 Process For Making Form I Of Olanzapine |
| 01/10/2008 | US20080009480 CYCLOPENTA[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES |
| 01/10/2008 | US20080008720 Substituted Tricyclic Heterocycles and their Uses |
| 01/09/2008 | EP1874739A1 Pharmaceutically active diazepanes |
| 01/09/2008 | CN101102776A Antitumor agent |
| 01/03/2008 | WO2008002820A2 Substituted benzyl amine compounds |
| 01/03/2008 | WO2008002583A1 Glycine transporter-1 inhibitors |
| 01/03/2008 | WO2007089657A3 Crystalline forms of a farnesyl dibenzodiazepinone |
| 01/03/2008 | US20080004261 Calcitonin Gene-Related Peptide (CGRP); headaches, pain, hot flashes; compounds are based on 3-substituted-5-(piperidinocarbonylmethyl)-thiazolidin-4-one moiety and ring derivatives thereof |
| 01/03/2008 | US20080004259 Anticancer agents; initiating mitosis which causes tumor cell death |
| 01/03/2008 | US20080004258 such as [2-(3,4-Dichloro-phenoxy)-5-(4-morpholin-4-yl-but-1-ynyl)-benzyl]-methyl-amine, used as H3 receptor and/or serotonin transporter modulators useful in the treatment of cognitive, sleep and psychological disorders |
| 01/03/2008 | CA2656089A1 Substituted benzyl amine compounds |
| 01/03/2008 | CA2655159A1 Glycine transporter-1 inhibitors |
| 01/01/2008 | US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 12/27/2007 | US20070299059 Compostions and methods relating to novel compounds and targets thereof |
| 12/27/2007 | US20070299058 Anxiolytic Agents With Reduced Sedative And Ataxic Effects |
| 12/26/2007 | EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors |
| 12/26/2007 | CN101092417A Folacin analogue, and salt of folacin analogue in use for medical treatment |
| 12/20/2007 | US20070293482 Process for Preparing Benzodiazepines |
| 12/20/2007 | US20070293478 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses |
| 12/19/2007 | EP1867639A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 12/19/2007 | EP1866311A2 Novel compounds |
| 12/19/2007 | EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 12/19/2007 | EP1032556B1 Pharmaceutically active compounds and methods of use |
| 12/13/2007 | US20070287699 Antiviral agents |
| 12/13/2007 | US20070287697 Cgrp Receptor Antagonists |
| 12/13/2007 | US20070287696 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 12/12/2007 | EP1863776A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 12/12/2007 | EP1863775A2 Process for preparing crystalline form i of olanzapine |
| 12/12/2007 | EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 12/12/2007 | EP1268481B1 Kinase inhibitors as therapeutic agents |
| 12/11/2007 | US7307074 Diazepan derivatives or salts thereof |
| 12/06/2007 | WO2007140213A1 Pyridoazepine derivatives |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007139002A1 Method for producing nitrogen-containing fused ring compound |
| 12/06/2007 | WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2650514A1 Salts and crystal modifications thereof |
| 12/05/2007 | EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
| 12/05/2007 | CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
| 12/04/2007 | US7304056 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease |
| 12/04/2007 | US7304055 Succinoylamino lactams as inhibitors of Aβ protein production |
| 12/04/2007 | US7304054 Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals |
| 12/04/2007 | US7304049 Succinamides N-monosubstituted with with a dibenzo[b,e]azepinone group that inhibit the production of A beta-peptide, acting to prevent the formation of neurological deposits of amyloid protein; treating Alzheimer's Disease |
| 12/04/2007 | US7304048 For use as anti-inflammatory agents |
| 11/29/2007 | WO2007135295A2 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same |
| 11/29/2007 | WO2007035722A8 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
| 11/29/2007 | WO2006127331A3 Conversion process for 2,3-benzodiazepine enantiomers |
| 11/29/2007 | US20070275954 Novel Fused Heterocycles and Uses Thereof |
| 11/29/2007 | US20070275952 Tie-2 Modulators and Methods of Use |
| 11/29/2007 | CA2649685A1 Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation et utilisation connexes, et compositions contenant lesdits derives |
| 11/28/2007 | CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors |
| 11/22/2007 | WO2007095495A3 Benzodiazepine gcnf modulators for stem cell modulation |
| 11/22/2007 | US20070270412 Novel pharmaceuticals |
| 11/22/2007 | US20070270411 Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors |
| 11/22/2007 | US20070270410 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders |
| 11/22/2007 | US20070270409 Medicament for Preventing and/or Treating Ischemic Cardiovascular Disease |
| 11/21/2007 | EP1856075A1 Substituted arylamine compounds and their use as 5-ht6 modulators |
| 11/21/2007 | CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound |
| 11/21/2007 | CN100349890C Quinazoline(di) ones for invertebrate pest control |
| 11/20/2007 | US7297524 Polynucleotides for production of farnesyl dibenzodiazepinones |
| 11/15/2007 | WO2007130499A2 Antiviral agents |
| 11/15/2007 | WO2007050401A3 Tyrosine kinase inhibitors |
| 11/15/2007 | US20070265248 Substituted piperazines and methods of use |
| 11/15/2007 | US20070265193 Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 11/14/2007 | EP1853569A1 Ligands for g-protein coupled receptors |
| 11/14/2007 | EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 11/14/2007 | CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 11/14/2007 | CN100348600C Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors |
| 11/13/2007 | US7294632 E.g., 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; treating non-insulin dependent diabetes |
| 11/08/2007 | WO2007107352A8 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 11/08/2007 | US20070259857 Amorphous form of Olanzapine |
| 11/08/2007 | US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents |
| 11/08/2007 | US20070256352 Substituted hexahydro-1,4-diazepin-5-ones and compositions stabilized therewith |
| 11/08/2007 | CA2647678A1 Diazepan orexin receptor antagonists |
| 11/07/2007 | EP1851207A2 Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/07/2007 | EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor |
| 11/06/2007 | US7291617 Arylamidine derivative or salt thereof |
| 11/01/2007 | WO2007122411A1 Diazepan-1-yl-sulfonyl derivatives for the treatment of metabolic syndrome |
| 11/01/2007 | WO2007122103A1 Diazepan derivatives modulators of chemokine receptors |
| 11/01/2007 | WO2007053193A3 Unsolvated benzodiazepine compositions and methods |
| 11/01/2007 | US20070254894 Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation |
| 11/01/2007 | US20070254870 3-Benzyl-7-chloro-2-[2-methyl-1-(7-oxo-[1,4]diazepan-1-yl)-propyl]-3H-quinazolin-4-one; mitotic kinesin KSP inhibitors; dysfunction of mitotic spindle, resulting in cell cycle arrest and cell death; anticarcinogenic, antiinflammatory, antiproliferative agents |
| 11/01/2007 | US20070254867 Heterocyclic Kinase Inhibitors |
| 11/01/2007 | US20070254865 Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes |
| 11/01/2007 | US20070254346 Process for producing farnesylated dibenzodiazepinone by fermentation |
| 11/01/2007 | CA2649636A1 Diazepan derivatives modulators of chemokine receptors |
| 10/31/2007 | EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors |
| 10/31/2007 | EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 10/31/2007 | EP1848506A2 Pyrimidine-fused diazepine derivatives and indole-fused pteridines |
| 10/31/2007 | EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors |
| 10/31/2007 | CN101065365A Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions |
| 10/30/2007 | US7288549 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents |
| 10/25/2007 | US20070249590 Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders |
| 10/18/2007 | WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof |
| 10/18/2007 | US20070244098 Dual Small Molecule Inhibitors of Cancer and Angiogenesis |
| 10/18/2007 | US20070244097 Nicotinic AcetylcholineReceptor Ligands |